Determination of iodixanol hemodialysis clearance using a novel in vitro system

Clinical Research and Regulatory Affairs

Volumn 13, Issue 2, 1996, Pages 111-124

  Bailie, George R ^b   Eisele, George ^b   Sala, Joseph ^b   Wu, Danlin ^b  

^a ALBANY MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELLULOSE; IODIXANOL; POLYSULFONE; SODIUM CHLORIDE; UREA;

ANEMIA; AREA UNDER THE CURVE; ARTICLE; ARTIFICIAL MEMBRANE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; NORMAL HUMAN; UREMIA;

EID: 0029876044     PISSN: 10601333     EISSN: None     Source Type: Journal    
DOI: 10.3109/10601339609005303     Document Type: Article

References (4)

1. Barrett, BJ. Contrast nephrotoxicity: a review. J. Am. Soc. Nephrol., 5, 125-137 (1994).
2. Nilsson-Ehle, P., Moon, S., Back, E. S., Kurkas, J. Hemodialysis to prevent contrast media nephrolpathy: a study in patients with impaired renal function. J. Am. Soc. Nephrol., 3, 382 (1992). Abstract.
3. Sigdell, J. E. Operating characteristics of hollow-fiber dialyzers. In, Nissensen, A. R., Fine, R. N., Gentile, D. E. (Eds.) Clinical Dialysis (2nd edn). Appleton & Lange, Norwalk, CT, 1990, 97-117.
4. Matzke, G. R. Pharmacotherapeutic consequences of recent advances in hemodialysis therapy. Ann. Pharmacother., 28, 512-514 (1994).